financially supported by National Natural Science Foundation of China (No. 22077018);National Key R&D Program of China (No. 2017YFA0506000)。
A novel series of CHOR-HEPT non-nucleoside HIV-1 reverse transcriptase inhibitors were developed by means of structure-based design strategy based on compound 6 reported previously by our group. Most of these compound...
supported by the National MegaProject for Infectious Disease (2018ZX10301408, China);the National Mega-Project for Significant New Drug Discovery (2018ZX09711003-002-002, China);the National Natural Science Foundation of China (81802019 and 81902075);the Beijing Natural Science Foundation (7184228, China);CAMS Innovation Fund for Medical Sciences (2018-I2M-3-004 and 2020-I2M-2010, China);the Peking Union Medical College Youth Fund (3332016063 and 3332018096, China)。
Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2) has become one major threat to human population health.The RNA-dependent RNA polymerase(RdRp) presents an ideal target of antivirals,whereas nucleoside analo...
financial support from the National Natural Science Foundation of China(Nos.21967020,U1702286,21362017,21262044);Program for Changjiang Scholars and Innovative Research Team in University(No.IRT17R94,China);Fund of Academician Working Station of Yunnan Province(No.2018IC057)。
In continuation of our efforts toward the discovery of potent HIV-1 NNRTIs with diverse structures,a series of novel S-DACO analogues of 6-(2-cyclohexyl-1-allkyl)-2-(2-oxo-2-phenyl-ethylsulfanyl)pyrimidin-4(3 H)-ones ...
financially supported by National Natural Science Foundation of China under Grant Nos.21871055 and21372050;Shanghai Municipal Natural Science Foundation under Grant No.13ZR1402200(China).
In order to improve the positional adaptability of our previously reported naphthyl diaryltriazines(NP-DATAs),synthesis of a series of novel biphenyl-substituted diaryltriazines(BP-DATAs)with a flexible side chain att...
AIM To investigate the mechanism(s) by which potential effects of multi-drug highly-active antiretroviral therapy contributes to lipodystrophy syndrome. METHODS Preadipocytes from healthy donors were assessed for prol...
Supported by National Natural Science Foundation of China,No.31340023,No.91029741,No.81001072 and No.81171550;National Key Sci-Tech Special Project of China,No.2012ZX10002011-006;Specialized Research Fund for the Doctoral Program of Higher Education,No.20130001120075;Peking University People’s Hospital Research and Development Funds,No.RDB2013-02
Chronic infection with hepatitis B virus(HBV)constitutes a major global public health threat,causing substantial disease burdens such as liver cirrhosis and hepatocellular carcinoma,thus representing high unmet medica...
Aim: To investigate the action of isothiafludine (NZ-4), a derivative of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo...
National Natural Science Foundation of China (GrantNo.20972011,21042009)
A series of novel dihydro-alkylthio-benzyl-oxopyrimidines (S-DABOs) 7a-f have been designed and synthesized with an efficient method. Biological evaluation of their HIV-1 reverse transcriptase inhibitory activities ...
For the first time we report quantitative structure activity relationship (QSAR) studies based on Kier-Hall Electrotopological State (E-State) Indices for Dihydroalkoxybenzyloxopyrimidines (DABO) derivatives acting as...
There have been few reports evaluating the prevalence of genotypic mutations and antiretroviral resistance among chronic HIV-infected Veterans within the United States. This retrospective cross-sectional study charact...